Literature DB >> 7639801

Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis.

K R Bruckdorfer1, J B Hillary, T Bunce, R Vancheeswaran, C M Black.   

Abstract

OBJECTIVE: To examine the resistance to oxidation of low-density lipoproteins (LDL) from patients with systemic sclerosis (SSc) and primary Raynaud's phenomenon (RP) compared with healthy controls.
METHODS: Plasma LDL were isolated from patients with diffuse cutaneous and limited cutaneous SSc (dcSSc and lcSSc, respectively), patients with primary RP, and healthy control subjects. The lipoproteins were assessed for their resistance to oxidation in the presence of cupric ions, using spectrophotometric assays.
RESULTS: LDL from patients with dcSSc and lcSSc were more susceptible to oxidation than were those from healthy control subjects or patients with RP.
CONCLUSION: Our findings suggest that free radicals may play a role in the pathology of SSc.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639801     DOI: 10.1002/art.1780380807

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  25 in total

Review 1.  Combination therapies for systemic sclerosis.

Authors:  C P Denton; C M Black
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts.

Authors:  Pei-Suen Tsou; Nadine N Talia; Adam J Pinney; Ann Kendzicky; Sonsoles Piera-Velazquez; Sergio A Jimenez; James R Seibold; Kristine Phillips; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2011-12-12

3.  Serum lipid profile in patients with systemic sclerosis: relationship to the thyreometabolic state.

Authors:  P J Kotyla; J Gozdzik; M Lewicki; A T Kotulska; E J Kucharz
Journal:  Rheumatol Int       Date:  2005-11-12       Impact factor: 2.631

4.  Macrovascular disease and systemic sclerosis.

Authors:  M Ho; D Veale; C Eastmond; G Nuki; J Belch
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

5.  Oxidized low-density lipoprotein alters the effect of matrix stiffness on the formation of endothelial networks and capillary lumens.

Authors:  Madhu S Gundavaram; Tzu Pin Shentu; Gregory B Kowalsky; Suncica Volkov; Dean E Schraufnagel; Irena Levitan
Journal:  Pulm Circ       Date:  2013-12-05       Impact factor: 3.017

Review 6.  Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis.

Authors:  Karen Au; Manjit K Singh; Vijay Bodukam; Sangmee Bae; Paul Maranian; Rikke Ogawa; Brennan Spiegel; Maureen McMahon; Bevra Hahn; Dinesh Khanna
Journal:  Arthritis Rheum       Date:  2011-07

Review 7.  Microvascular involvement in systemic sclerosis and systemic lupus erythematosus.

Authors:  Didem Saygin; Kristin B Highland; Adriano R Tonelli
Journal:  Microcirculation       Date:  2019-04       Impact factor: 2.628

8.  Oxidative stress in Systemic Sclerosis.

Authors:  G Simonini; M M Cerinic; S Generini; M Zoppi; M Anichini; C Cesaretti; A Pignone; F Falcini; T Lotti; M Cagnoni
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

9.  Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.

Authors:  P G Vlachoyiannopoulos; N Tsifetaki; I Dimitriou; D Galaris; S A Papiris; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  1996-10       Impact factor: 19.103

Review 10.  Cardiorheumatology: cardiac involvement in systemic rheumatic disease.

Authors:  Megha Prasad; Joerg Hermann; Sherine E Gabriel; Cornelia M Weyand; Sharon Mulvagh; Rekha Mankad; Jae K Oh; Eric L Matteson; Amir Lerman
Journal:  Nat Rev Cardiol       Date:  2014-12-23       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.